Global Markets Direct is a cutting-edge provider of market research and business consultancies for a wide range of customers worldwide.
A team of analytics is capable to produce all sorts of market information and carry out extensive industry research using unique data and reliable sources to let customers know who they are at the market. Global Markets Direct has profound analytical experience in researching the industries and preparing customized reports across many specific fields.
The company is distinguished by its high-quality consulting products and close inspection of the issues under study. Diligent efforts of the experts make every piece of business information an exclusive source of feasible solutions and valuable advice.
With a commitment to serve every client need, Global Markets Direct collects and interprets the materials for the analysis, uses methods of primary and secondary research and develops one of a kind data packages for global clients. They are able to cover the tones of industry-related information to assist customers in taking the right business decisions and developing their strategic plans.
Under the supervision of skillful managers and experts, business analysts produce reports that include:
- Product portfolio
- Potentially strong market reviews
- Competitive analytics
- Prospect partners
- Mergers and acquisitions project data
- Latest trends across a particular industry area
- Research and development strategies
- The analysis of new customers
- A set of remedial measures for projects
They will search for new partners and highlight the current business issues plus develop new strategies and tactical steps to help you take the lead in the industry where you operate.
Publications found:
5,853
Sort by:
Myopia (Ophthalmology) - Drugs in Development, 2021
US$ 2,000.00
Myopia (Ophthalmology) - Drugs in Development, 2021 SUMMARY Myopia (Ophthalmology) - Drugs in Development, 2021 provides an overview of the Myopia pipeline landscape. The report provides comprehensive...
April 2021
35 pages
Myxoid Liposarcoma (Oncology) - Drugs in Development, 2021
US$ 2,000.00
Myxoid Liposarcoma (Oncology) - Drugs in Development, 2021 SUMMARY Myxoid Liposarcoma (Oncology) - Drugs in Development, 2021 provides an overview of the Myxoid Liposarcoma pipeline landscape. The rep...
April 2021
35 pages
Nausea (Gastrointestinal) - Drugs in Development, 2021
US$ 2,000.00
Nausea (Gastrointestinal) - Drugs in Development, 2021 SUMMARY Nausea (Gastrointestinal) - Drugs in Development, 2021 provides an overview of the Nausea pipeline landscape. The report provides compreh...
April 2021
40 pages
Niemann Pick C1 Protein (NPC1) - Drugs in Development, 2021
US$ 3,000.00
Niemann Pick C1 Protein (NPC1) - Drugs in Development, 2021 SUMMARY Niemann Pick C1 Protein (NPC1) - Drugs in Development, 2021 provides in depth analysis on Niemann Pick C1 Protein (NPC1) targeted pi...
April 2021
30 pages
Nonstructural Protein 1 (NS1) - Drugs in Development, 2021
US$ 3,000.00
Nonstructural Protein 1 (NS1) - Drugs in Development, 2021 SUMMARY Nonstructural Protein 1 (NS1) - Drugs in Development, 2021 provides in depth analysis on Nonstructural Protein 1 (NS1) targeted pipel...
April 2021
35 pages
Nonstructural Protein 3 (NS3) - Drugs in Development, 2021
US$ 3,000.00
Nonstructural Protein 3 (NS3) - Drugs in Development, 2021 SUMMARY Nonstructural Protein 3 (NS3) - Drugs in Development, 2021 provides in depth analysis on Nonstructural Protein 3 (NS3) targeted pipel...
April 2021
30 pages
